Summary
Paul Danese is a co-founder and scientist with over a decade of experience specializing in adverse event database search and analysis, particularly FDA MAUDE and FAERS/AERS datasets. He leverages a strong academic foundation (Ph.D. and M.A. in Molecular Biology from Princeton) and years in pharmaceutical R&D to translate complex biomedical data into actionable safety insights. Based in Glastonbury, CT, he blends deep domain expertise with entrepreneurial experience running FDAble LLC since 2009. His background as a postdoc at Harvard and senior scientist roles at Rib-X and Microbia underscores a career that bridges rigorous research and practical industry applications. Notably, his work focuses on making noisy regulatory data tractable for device and drug safety evaluation—a niche that combines technical analysis with regulatory fluency.
11 years of coding experience
8 years of employment as a software developer
B.S., Biochemistry, B.S., Biochemistry at University of Massachusetts Amherst
Pittsfield High School
Ph.D., Molecular Biology, Ph.D., Molecular Biology at Princeton University